February 22, 2018 / 2:11 PM / 3 months ago

BRIEF-Nuuvera Enters Into Definitive Agreement To Acquire Remaining Interest In ARA-Avanti Rx Analytics

Feb 22 (Reuters) - Nuuvera Inc:

* NUUVERA ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE REMAINING INTEREST IN ARA-AVANTI RX ANALYTICS INC.

* NUUVERA ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE REMAINING INTEREST IN ARA-AVANTI RX ANALYTICS INC.

* NUUVERA INC - ‍TOTAL CONSIDERATION FOR AVANTI TRANSACTION IS EXPECTED TO BE APPROXIMATELY $43 MILLION​

* NUUVERA INC - ‍PURSUANT TO AGREEMENT, PURCHASE PRICE FOR 49% INTEREST OF AVANTI IS $35 MILLION​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below